Outfielder Jose Guillen will be asked to talk to MLB’s Mitchell Investigators about his reported use of steroids and HGH, but that committee has no subpoena powers – and Guillen’s value on the free agent market appears unchanged.
Baseball continues to fight itself over the issue of performance-enhancing drugs. In the midst of rumors and accusations, even confessions of HGH use, Cleveland picked up the $7.5 million option on pitcher Paul Byrd.
And the Kansas City Royals say they’re not deterred by the reports of Guillen’s spending $19,000 on similar drugs between 2002 and 2005.
"You’re talking about a period of time in baseball that we all know circumstances like this were occurring," GM Dayton Moore said. "You’ve got to put it into perspective."
Guillen’s agent, Adam Katz, couldn’t have said it better.